Stem Cell Transplantation for Autoimmune Diseases

Cellular Transplantation

Volumn , Issue , 2007, Pages 241-257

  Tyndall, Alan ^a   Le Blanc, Katarina ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882546047     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369415-7/50014-4     Document Type: Chapter

References (114)

1. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
2. Almeida-Porada G., Porada C.D., Tran N., Zanjani E.D. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell in bone marrow at later time points after transplantation. Blood 2000, 95:3620-3627.
3. Angelopoulou M., Novelli E., Grove J.E., Rinder H.M., Civin C., Cheng L., Krause D.S. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol 2003, 31:413-420.
4. Baron F.A., Hermanne J.P., Dowlati A., Weber T., Thiry A., Fassotte M.F., Fillet G., Beguin Y. Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998, 21:951-954.
5. Barry F., Boynton R., Murphy M., Haynesworth S., Zaia J. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun 2001, 289:519-524.
6. Barry F.P., Boynton R.E., Haynesworth S., Murphy J.M., Zaia J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 1999, 265:134-139.
7. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002, 30:42-48.
8. Binks M., Passweg J.R., Furst D., McSweeney P., Sullivan K., Besenthal C., Finke J., Peter H.H., van Laar J., Breedveld F.C., Fibbe W.E., Farge D., Gluckman E., Locatelli F., Martini A., van den Hoogen F., van de Putte L., Schattenberg A.V., Arnold R., Bacon P.A., Emery P., Espigado I., Hertenstein B., Hiepe F., Kashyap A., Kotter I., Marmont A., Martinez A., Pascual M.J., Gratwohl A., Prentice H.G., Black C., Tyndall A. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: Procedure related mortality and impact on skin disease. Ann Rheum Dis 2001, 60:577-584.
9. Burt R.K., Oyama Y., Verda L., Quigley K., Brush M., Yaung K., Statkute L., Traynor A., Barr W.G. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum 2004, 50:2466-2470.
10. Cheng L., Qasba P., Vanguri P., Thiede M.A. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells. J Cell Physiol 2000, 184:58-69.
11. Chiang M.K., Flanagan J.G. Interactions between the Flk-1 receptor, vascular endothelial growth factor, and cell surface proteoglycan identified with a soluble receptor reagent. Growth Factors 1995, 12:1-10.
12. Clave E., Agbalika F., Bajzik V., de Latour R.P., Trillard M., Rabian C., Scieux C., Devergie A., Socie G., Ribaud P., Ades L., Ferry C., Gluckman E., Charron D., Esperou H., Toubert A., Moins-Teisserenc H. Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: Relationship between viral load, EBV-specific T-cell reconstitution and rituxim. Transplantation 2004, 77:76-84.
13. Conget P.A., Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999, 181:67-73.
14. Davidson A., Diamond B. Autoimmune diseases. N Engl J Med 2001, 345:340-350.
15. De Stefano P., Zecca M., Giorgiani G., Perotti C., Giraldi E., Locatelli F. Resolution of immune haemolytic anaemia with allogeneic bone marrow transplantation after an unsuccessful autograft. Br J Haematol 1999, 106:1063-1064.
16. Deans R.J., Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000, 28:875-884.
17. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., Gianni A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
18. Djouad F., Fritz V., Apparailly F., Louis-Plence P., Bony C., Sany J., Jorgensen C., Noel D. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005, 52:1595-1603.
19. Djouad F., Plence P., Bony C., Tropel P., Apparailly F., Sany J., Noel D., Jorgensen C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003, 102:3837-3844.
20. Douek D.C., Vescio R.A., Betts M.R., Brenchley J.M., Hill B.J., Zhang L., Berenson J.R., Collins R.H., Koup R.A. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000, 355:1875-1881.
21. Einsele H., Bertz H., Beyer J., Kiehl M.G., Runde V., Kolb H.J., Holler E., Beck R., Schwerdfeger R., Schumacher U., Hebart H., Martin H., Kienast J., Ullmann A.J., Maschmeyer G., Kruger W., Niederwieser D., Link H., Schmidt C.A., Oettle H., Klingebiel T. Infectious complications after allogeneic stem cell transplantation: Epidemiology and interventional therapy strategies-guidelines of the Infectious DiseasesWorking Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003, 82(Suppl 2):175-185.
22. Fang B., Shi M., Liao L., Yang S., Liu Y., Zhao R.C. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 2004, 78:83-88.
23. Farge D., Henegar C., Carmagnat M., Daneshpouy M., Marjanovic Z., Rabian C., Ilie D., Douay C., Mounier N., Clave E., Bengoufa D., Cabane J., Marolleau J.P., Gluckman E., Charron D., Toubert A. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum 2005, 52:1555-1563.
24. Farge D., Marolleau J.P., Zohar S., Marjanovic Z., Cabane J., Mounier N., Hachulla E., Philippe P., Sibilia J., Rabian C., Chevret S., Gluckman E. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: Early results from a French multicentre phase I-II study. Br J Haematol 2002, 119:726-739.
25. Farge D., Passweg J., van Laar J.M., Marjanovic Z., Besenthal C., Finke J., Peter H.H., Breedveld F.C., Fibbe W.E., Black C., Denton C., Koetter I., Locatelli F., Martini A., Schattenberg A.V., van den Hoogen F., van de Putte L., Lanza F., Arnold R., Bacon P.A., Bingham S., Ciceri F., Didier B., Diez-Martin J.L., Emery P., Feremans W., Hertenstein B., Hiepe F., Luosujarvi R., Leon Lara A., Marmont A., Martinez A.M., Pascual Cascon H., Bocelli-Tyndall C., Gluckman E., Gratwohl A., Tyndall A. Autologous stem cell transplantation in the treatment of systemic sclerosis: Report from the EBMT/EULAR Registry. Ann Rheum Dis 2004, 63:974-981.
26. Fassas A., Passweg J.R., Anagnostopoulos A., Kazis A., Kozak T., Havrdova E., Carreras E., Graus F., Kashyap A., Openshaw H., Schipperus M., Deconinck E., Mancardi G., Marmont A., Hansz J., Rabusin M., Zuazu Nagore F.J., Besalduch J., Dentamaro T., Fouillard L., Hertenstein B., La Nasa G., Musso M., Papineschi F., Rowe J.M., Saccardi R., Steck A., Kappos L., Gratwohl A., Tyndall A., Samijn J., Samign J. Hematopoietic stem cell transplantation for multiple sclerosis: A retrospective multicenter study. J Neurol 2002, 249:1088-1097.
27. Feldmann M., Steinman L. Design of effective immunotherapy for human autoimmunity. Nature 2005, 435:612-619.
28. Friedenstein A.J., Deriglasova U.F., Kulagina N.N., Panasuk A.F., Rudakowa S.F., Luria E.A., Ruadkow I.A. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974, 2:83-92.
29. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., Frolova G.P. Heterotopic of bone marrow: Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968, 6:230-247.
30. Glennie S., Soeiro I., Dyson P.J., Lam E.W., Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005, 105:2821-2827.
31. Gratwohl A., Passweg J., Bocelli-Tyndall C., Fassas A., van Laar J.M., Farge D., Andolina M., Arnold R., Carreras E., Finke J., Kotter I., Kozak T., Lisukov I., Lowenberg B., Marmont A., Moore J., Saccardi R., Snowden J.A., van den Hoogen F., Wulffraat N.M., Zhao X.W., Tyndall A. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005, 35:869-879.
32. Gratwohl A., Passweg J., Gerber I., Tyndall A. Stem cell transplantation for autoimmune diseases. Best Pract Res Clin Haematol 2001, 14:755-776.
33. Gratwohl A., Tyndall A. Hematopoietic stem cell transplantations in treatment of autoimmune diseases. Z Rheumatol 1997, 56:173-177.
34. Grinnemo K.H., Mansson A., Dellgren G., Klingberg D., Wardell E., Drvota V., Tammik C., Holgersson J., Ringden O., Sylven C., Le Blanc K. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg 2004, 127:1293-1300.
35. Hawkey C.J., Snowden J.A., Lobo A., Beglinger C., Tyndall A. Stem cell transplantation for inflammatory bowel disease: Practical and ethical issues. Gut 2000, 46:869-872.
36. Haynesworth S.E., Goshima J., Goldberg V.M., Caplan A.I. Characterization of cells with osteogenic potential from human marrow. Bone 1992, 13:81-88.
37. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., Muul L., Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy. Proc Natl Acad Sci USA 2002, 99:8932-8937.
38. Ikehara S., Yasumizu R., Inaba M., Izui S., Hayakawa K., Sekita K., Toki J., Sugiura K., Iwai H., Nakamura T., et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1989, 86:3306-3310.
39. Anker P.S., Noort W.A., Kruisselbrink A.B., Scherjon S.A., Beekhuizen W., Willemze R., Kanhai H.H., Fibbe W.E. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2003, 31:881-889.
40. Jayne D., Passweg J., Marmont A., Farge D., Zhao X., Arnold R., Hiepe F., Lisukov I., Musso M., Ou-Yang J., Marsh J., Wulffraat N., Besalduch J., Bingham S.J., Emery P., Brune M., Fassas A., Faulkner L., Ferster A., Fiehn C., Fouillard L., Geromin A., Greinix H., Rabusin M., Saccardi R., Schneider P., Zintl F., Gratwohl A., Tyndall A. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004, 13:168-176.
41. Jayne D., Tyndall A. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004, 13:359-365.
42. Jones E.A., Kinsey S.E., English A., Jones R.A., Straszynski L., Meredith D.M., Markham A.F., Jack A., Emery P., McGonagle D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002, 46:3349-3360.
43. Kalwak K., Gorczynska E., Toporski J., Turkiewicz D., Slociak M., Ussowicz M., Latos-Grazynska E., Krol M., Boguslawska-Jaworska J., Chybicka A. Immune reconstitution after haematopoietic cell transplantation in children: Immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol 2002, 118:74-89.
44. Kamradt T., Mitchison N.A. Tolerance and autoimmunity. N Engl J Med 2001, 344:655-664.
45. Khorshid O., Hosing C., Bibawi S., Ueno N., Reveille J., Mayes M.D., Champlin R.E. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. J Rheumatol 2004, 31:2513-2516.
46. Klyushnenkova E., Mosca J.D., Zernetkina V., Majumdar M.K., Beggs K.J., Simonetti D.W., Deans R.J., McIntosh K.R. T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression. J Biomed Sci 2005, 12:47-57.
47. Knaan-Shanzer S., Houben P., Kinwel-Bohre E.P., van Bekkum D.W. Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1991, 8:333-338.
48. Koc O.N., Day J., Nieder M., Gerson S.L., Lazarus H.M., Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002, 30:215-222.
49. Koc O.N., Gerson S.L., Cooper B.W., Dyhouse S.M., Haynesworth S.E., Caplan A.I., Lazarus H.M. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000, 18:307-316.
50. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003, 101:3722-3729.
51. Kronenberg M., Rudensky A. Regulation of immunity by selfreactive T cells. Nature 2005, 435:598-604.
52. Lazarus H.M., Haynesworth S.E., Gerson S.L., Rosenthal N.S., Caplan A.I. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic u. Bone Marrow Transplant 1995, 16:557-564.
53. Lazarus H.M., Koc O.N., Devine S.M., Curtin P., Maziarz R.T., Holland H.K., Shpall E.J., McCarthy P., Atkinson K., Cooper B.W., Gerson S.L., Laughlin M.J., Loberiza F.R., Moseley A.B., Bacigalupo A. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005, 11:389-398.
54. Le Blanc K., Gotherstrom C., Ringden O., Hassan M., McMahon R., Horwitz E., Anneren G., Axelsson O., Nunn J., Ewald U., Norden-Lindeberg S., Jansson M., Dalton A., Astrom E. Westgren, M. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005, 79:1607-1614.
55. Le Blanc K., Rasmusson I., Gotherstrom C., Seidel C., Sundberg B., Sundin M., Rosendahl K., Tammik C., Ringden O. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin- activated lymphocytes. Scand J Immunol 2004, 60:307-315.
56. Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M., Ringden O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363:1439-1441.
57. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003, 31:890-896.
58. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003, 57:11-20.
59. Lewin S.R., Heller G., Zhang L., Rodrigues E., Skulsky E., van den Brink M.R., Small T.N., Kernan N.A., O'Reilly R.J., Ho D.D., Young J.W. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood 2002, 100:2235-2242.
60. Liechty K.W., MacKenzie T.C., Shaaban A.F., Radu A., Moseley A.M., Deans R., Marshak D.R., Flake A.W. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000, 6:1282-1286.
61. Maccario R., Podesta M., Moretta A., Cometa A., Comoli P., Montagna D., Daudt L., Ibatici A., Piaggio G., Pozzi S., Frassoni F., Locatelli F. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005, 90:516-525.
62. Maitra B., Szekely E., Gjini K., Laughlin M.J., Dennis J., Haynesworth S.E., Koc O.N. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 2004, 33:597-604.
63. Majumdar M.K., Banks V., Peluso D.P., Morris E.A. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol 2000, 185:98-106.
64. Majumdar M.K., Keane-Moore M., Buyaner D., Hardy W.B., Moorman M.A., McIntosh K.R., Mosca J.D. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 2003, 10:228-241.
65. Marmont A.T.A., Gratwohl A., Vischer T. Haemopoietic precursor-cell transplants for autoimmune diseases. Lancet 1995, 345:978.
66. Marmont A.M. Stem cell transplantation for autoimmune disorders: Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract Res Clin Haematol 2004, 17:223-232.
67. Marmont A.M., Gualandi F., Van Lint M.T., Bacigalupo A. Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versusautoimmunity effect. Bone Marrow Transplant 2003, 31:399-402.
68. Matzinger P. The danger model: A renewed sense of self. Science 2002, 296:301-305.
69. McKendry R.J., Huebsch L., Leclair B. Progression of rheumatoid arthritis following bone marrow transplantation: A case report with a 13-year followup. Arthritis Rheum 1996, 39:1246-1253.
70. McSweeney P.A., Nash R.A., Storb R., Furst D.E., Gauthier J., Sullivan K.M. Autologous stem cell transplantation for autoimmune diseases: Issues in protocol development. J Rheumatol Suppl 1997, 48:79-84.
71. McSweeney P.A., Nash R.A., Sullivan K.M., Storek J., Crofford L.J., Dansey R., Mayes M.D., McDonagh K.T., Nelson J.L., Gooley T.A., Holmberg L.A., Chen C.S., Wener M.H., Ryan K., Sunderhaus J., Russell K., Rambharose J., Storb R., Furst D.E. High-dose immunosuppressive therapy for severe systemic sclerosis: Initial outcomes. Blood 2002, 100:1602-1610.
72. Medzhitov R., Janeway C.A. Decoding the patterns of self and nonself by the innate immune system. Science 2002, 296:298-300.
73. Meisel R., Zibert A., Laryea M., Gobel U., Daubener W., Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004, 103:4619-4621.
74. Minchinton R.M., Waters A.H., Kendra J., Barrett A.J. Autoimmune thrombocytopenia acquired from an allogeneic bone-marrow graft. Lancet 1982, 2:627-629.
75. Moore J., Brooks P., Milliken S., Biggs J., Ma D., Handel M., Cannell P., Will R., Rule S., Joske D., Langlands B., Taylor K., O'Callaghan J., Szer J., Wicks I., McColl G., Passeullo F., Snowden J. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002, 46:2301-2309.
76. Morris D.G., Huang X., Kaminski N., Wang Y., Shapiro S.D., Dolganov G., Glick A., Sheppard D. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature 2003, 422:169-173.
77. Nakahara H., Dennis J.E., Bruder S.P., Haynesworth S.E., Lennon D.P., Caplan A.I. In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res 1991, 195:492-503.
78. Ortiz L.A., Gambelli F., McBride C., Gaupp D., Baddoo M., Kaminski N., Phinney D.G. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003, 100:8407-8411.
79. Oyama Y., Craig R.M., Traynor A.E., Quigley K., Statkute L., Halverson A., Brush M., Verda L., Kowalska B., Krosnjar N., Kletzel M., Whitington P.F., Burt R.K. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 2005, 128:552-563.
80. Petri M., Jones R.J., Brodsky R.A. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum 2003, 48:166-173.
81. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
82. Pochampally R.R., Neville B.T., Schwarz E.J., Li M.M., Prockop D.J. Rat adult stem cells (marrow stromal cells) engraft and differentiate in chick embryos without evidence of cell fusion. Proc Natl Acad Sci USA 2004, 101:9282-9285.
83. Prakken B.J., Roord S., Ronaghy A., Wauben M., Albani S., van Eden W. Heat shock protein 60 and adjuvant arthritis: A model for T cell regulation in human arthritis. Springer Semin Immunopathol 2003, 25:47-63.
84. Prakken B.J., Samodal R., Le T.D., Giannoni F., Yung G.P., Scavulli J., Amox D., Roord S., de Kleer I., Bonnin D., Lanza P., Berry C., Massa M., Billetta R., Albani S. Epitopespecific immunotherapy induces immune deviation of proin- flammatory T cells in rheumatoid arthritis. Proc Natl Acad Sci USA 2004, 101:4228-4233.
85. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
86. Rasmusson I., Ringden O., Sundberg B., Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 2005, 305:33-41.
87. Rasmusson I., Ringden O., Sundberg B., Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003, 76:1208-1213.
88. Roep B.O., Atkinson M. Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal. Diabetologia 2004, 47:1650-1656.
89. Rouquette-Gally A.M., Boyeldieu D., Gluckman E., Abuaf N., Combrisson A. Autoimmunity in 28 patients after allogeneic bone marrow transplantation: Comparison with Sjogren syndrome and scleroderma. Br J Haematol 1987, 66:45-47.
90. Rouquette-Gally A.M., Boyeldieu D., Prost A.C., Gluckman E. Autoimmunity after allogeneic bone marrow transplantation: A study of 53 long-term-surviving patients. Transplantation 1988, 46:238-240.
91. Saito T., Kuang J.Q., Bittira B., Al-Khaldi A., Chiu R.C. Xenotransplant cardiac chimera: Immune tolerance of adult stem cells. Ann Thorac Surg 2002, 74:19-24. discussion 24.
92. Sampath T.K., Nathanson M.A., Reddi A.H. In vitro transformation of mesenchymal cells derived from embryonic muscle into cartilage in response to extracellular matrix components of bone. Proc Natl Acad Sci USA 1984, 81:3419-3423.
93. Scime R., Cavallaro A.M., Tringali S., Santoro A., Rizzo A., Montalbano L., Casa A., Cottone M. Complete clinical remission after high-dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn's disease refractory to immunosuppressive and immunomodulator therapy. Inflamm Bowel Dis 2004, 10:892-894.
94. Shevach E.M. CD4+ CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol 2002, 2:389-400.
95. Shilling H.G., McQueen K.L., Cheng N.W., Shizuru J.A., Negrin R.S., Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003, 101:3730-3740.
96. Slavin S., Nagler A., Varadi G., Or R. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemi psoriasis and psoriatic polyarthritis. Exp Hematol 2000, 28:853-857.
97. Snowden J.A., Heaton D.C. Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: Further evidence for adoptive autoimmunity. Br J Dermatol 1997, 137:130-132.
98. Snowden J.A., Passweg J., Moore J.J., Milliken S., Cannell P., Van Laar J., Verburg R., Szer J., Taylor K., Joske D., Rule S., Bingham S.J., Emery P., Burt R.K., Lowenthal R.M., Durez P., McKendry R.J., Pavletic S.Z., Espigado I., Jantunen E., Kashyap A., Rabusin M., Brooks P., Bredeson C., Tyndall A. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis:Areport from the EBMT and ABMTR. J Rheumatol 2004, 31:482-488.
99. Sonwalkar S.A., James R.M., Ahmad T., Zhang L., Verbeke C.S., Barnard D.L., Jewell D.P., Hull M.A. Fulminant Crohn's colitis after allogeneic stem cell transplantation. Gut 2003, 52:1518-1521.
100. Statkute L., Traynor A., Oyama Y., Yaung K., Verda L., Krosnjar N., Burt R.K. Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation. Blood 2005.
101. Storek J., Dawson M.A., Storer B., Stevens-Ayers T., Maloney D.G., Marr K.A., Witherspoon R.P., Bensinger W., Flowers M.E., Martin P., Storb R., Appelbaum F.R., Boeckh M. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001, 97:3380-3389.
102. Sturfelt G., Lenhoff S., Sallerfors B., Nived O., Truedsson L., Sjoholm A.G. Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): Successful outcome in the recipient and induction of an SLE f in the donor. Ann Rheum Dis 1996, 55:638-641.
103. Sykes M., Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005, 435:620-627.
104. Tamm M., Gratwohl A., Tichelli A., Perruchoud A.P., Tyndall A. Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease. Ann Rheum Dis 1996, 55:779-780.
105. Traynor A.E., Barr W.G., Rosa R.M., Rodriguez J., Oyama Y., Baker S., Brush M., Burt R.K. Hematopoietic stem cell transplantation for severe and refractory lupus: Analysis after five years and fifteen patients. Arthritis Rheum 2002, 46:2917-2923.
106. Traynor A.E., Corbridge T.C., Eagan A.E., Barr W.G., Liu Q., Oyama Y., Burt R.K. Prevalence and reversibility of pulmonary dysfunction in refractory systemic lupus: Improvement correlates with disease remission following hematopoietic stem transplantation. Chest 2005, 127:1680-1689.
107. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 2003, 75:389-397.
108. Tyndall A., Gratwohl A. Hemopoietic blood and marrow transplants in the treatment of severe autoimmune disease. Curr Opin Hematol 1997, 4:390-394.
109. van Bekkum D.W. Stem cell transplantation for autoimmune disorders. Preclinical experiments. Best Pract Res Clin Haematol 2004, 17:201-222.
110. Van Laar J.M., Tyndall A. Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: A review. Cancer Control 2003, 10:57-65.
111. Wulffraat N.M., de Kleer I.M., Prakken B.J., Kuis W. Stem cell transplantation for autoimmune disorders: Refractory juvenile idiopathic arthritis. Best Pract Res Clin Haematol 2004, 17:277-289.
112. Wulffraat N.M., Sanders E.A., Kamphuis S.S., Rijkers G.T., Kuis W., Lilien M., Slaper-Cortenbach I.C. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus. Arthritis Rheum 2001, 44:728-731.
113. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., Uccelli A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood 2005.
114. Zheng S.G., Wang J.H., Gray J.D., Soucier H., Horwitz D.A. Natural and induced CD4+CD25+ cells educate CD4+CD25-cells to develop suppressive activity: The role of IL-2, TGF-beta, and IL-10. J Immunol 2004, 172:5213-5221.